Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Cancer Research

This content is Open Access.

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
 

Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)

Article DOI: 10.3791/55820 08:14 min May 4th, 2017
May 4th, 2017

Chapters

Summary

Tumor Treating Fields (TTFields) are an effective anti-tumor treatment modality delivered via the continuous, noninvasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields application to cell lines using a TTFields in vitro application system allows for the determination of the optimal frequency that leads to the highest reduction in cell counts.

Transcript

Tags

TTFields Inhibitory Frequency Cancerous Cells Tumor Treating Fields Optimal Frequency In Vitro Application System Clinical Administration Treatment Outcome TTField Parameters Pre-clinical Identification Specific Cancer Cell Line Combined Treatment Chemotherapy Agents Radiation Therapy Yaara Porat Researcher TTFields Dishes Base Plate Control Cells Coverslip U-87 MG Cells DMEM Medium Cell Overgrowth
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter